A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...
Singapore: Signostics, an Adelaide-based medical devices company, has unveiled its new ultrasound device Signos RT. The ...
Singapore: US-based PharmaJet entered into a collaboration with CSL to enable Afluria influenza vaccine to be deliver...
Singapore: iNova Pharmaceuticals, a Valeant company, is relocating its regional headquarters from Sydney, Australia, to ...
Singapore: Australia firm, Anatara Lifesciences, developer of therapeutics for gastrointestinal diseases for animals and...
Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...
Singapore: Australian biomedical company, Allied Healthcare, achieved successful results of its initial study of a novel...
Singapore: India's Strides Arcolab recently announced that two of its subsidiaries Strides Pharma Global (Singapore), an...
Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on gene...
Singapore: Novartis launched a topical diclofenac gel, which has been formulated with Australia-based Phosphagenics' pro...
Singapore: Sponsors and manufacturers of medical devices are now able to update adverse event reports that they have sub...
Singapore: Dr Randall Moshinsky, a cardio-thoracic surgeon in Australia, was frustrated by bleeding from the cut edge of...
Singapore: In a major development, Bionic Vision Australia researchers have successfully performed the first impla...
Singapore: National Health Performance Authority in Australia has revealed that while Australia has high immunization ra...
Singapore: Biotron has announced preliminary results from a human trial of its lead antiviral drug BIT225 to treat HIV i...
The life sciences sector in the Asia Pacific (APAC) region provides numerous opportunities for firms that are looking fo...
Singapore: Australia-based Phosphagenics recently announced the appointment of Dr Ross Murdoch as the chief executive of...
Singapore: Australia biotech firm, Mesoblast, has successfully concluded phase 2 trial of infusion of its cell therapy c...
Dr Silviu Itescu formed Mesoblast in 2004 to commercialize orthopedic applications of proprietary adult stem cell techno...
Singapore: Starpharma Holdings announced the results of an animal study which shows that a dendrimer-based formulation o...
Singapore: Sir Bob Geldof, widely recognised for his anti-poverty campaigns, slammed the developed nations for restricti...
Singapore: During their recent visit to India, Australian lifesciences and healthcare mission delegates highlighted that...
Singapore: Death, confusion, poverty, hunger, and hysteria are the concerns Africa is currently grappling with. Everywhe...
Singapore: Australian drug discovery firm, Imugene, has appointed Mr Charles Walker as Chief Executive Officer of Imugen...
